Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-20

Clinical Trial Update: Transforming Hypertension Treatment in Nigeria Using a Type II Hybrid, Interrupted Time Series Design [NA]

View source ↗

Summary

A completed clinical trial update describing a Type II Hybrid, interrupted time series design for transforming hypertension treatment in Nigeria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Washington University School of Medicine | Conditions: Hypertension | NA | Status: COMPLETED